ArticleFrontiers in endocrinology2026
Study on the predictive value of NHR and UHR levels in early pregnancy for gestational diabetes mellitus: based on a retrospective analysis.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to examine the relationship between the neutrophil to high-density lipoprotein cholesterol ratio (NHR) and the uric acid to high-density lipoprotein cholesterol ratio (UHR) in early pregnancy and the development of GDM, and to analyze the predictive value of these factors in combination, with a view to providing a basis for the early clinical prevention and treatment of GDM. Methods: The study population comprised primiparous women carrying a single fetus who received routine antenatal care and examinations at the Obstetrics Department of Yuncheng Central Hospital between January 2024 and December 2025. General clinical data were collected, along with results for blood tests, fasting glucose levels, and lipid profiles from weeks 10~13 of pregnancy. The results of the glucose tolerance test conducted between 24 and 28 weeks of gestation were used to divide the study participants into two groups: a GDM group and a non-GDM group. Results: Compared with the non-GDM group, patients in the GDM group exhibited significantly elevated levels of the inflammatory markers NHR and UHR ( Conclusion: Elevated levels of NHR and UHR in early pregnancy are positively correlated with the development of GDM. They constitute independent risk factors for its onset and possess a certain degree of predictive value, thereby providing a reference for the early clinical prevention and management of GDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.